Skip to main content

Table 1 Summary of Clinical Commissioning Group gluten-free prescribing policies in 2017

From: Breaking bread: examining the impact of policy changes in access to state-funded provisions of gluten-free foods in England

Policy type Frequency (%)
Partial restrictions on products and/or unitsa 70 (34%)
No ban 61 (29%)
Complete ban 46 (22%)
Policy under review 18 (9%)
Complete ban (with age-related exceptions)b 12 (6%)
  1. aPrescribing was limited to a lower number of monthly units or a restricted set of products which was largely dependent on the individual Clinical Commissioning Group
  2. bGluten-free products still prescribed for children/adolescents under the age of 18 or 19, and in some cases pregnant women